NRX Pharmaceuticals's total assets for Q3 2025 were $15.00M, an increase of 209.96% from the previous quarter. NRXP total liabilities were $40.75M for the fiscal quarter, a 0.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.